CDK5 and Parkinson disease: Furthermore, melatonin pretreatment reduced MPTP-induced loss of axon and dendritic length in dopaminergic neurons through suppression of autophagy activated by CDK5 and α-synuclein aggregation, thereby reducing dyskinesia symptoms in PD animal models [204,210,211,212].